NASDAQ · Health care

Pulsenmore Ltd. (PLSM)

Pulsenmore Ltd. reported revenue of $12.5M in fiscal 2025. It posted a net loss of $5M. In fiscal 2025 capital spending exceeded operating cash flow by $10.3M. At December 31, 2025 it held $6.8M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 30, 2026.

Watch PLSM in 60 seconds

Price

$1.52

0.00% on the day · November 11, 2026

52-week range $1.42 to $12.97

Market cap

$9.9M

Revenue (FY2025)

$12.5M

Net margin

-39.6%

Key facts about Pulsenmore Ltd.

Net worth: Pulsenmore Ltd. has a market value (market cap) of $9.9M at the latest share price, and shareholders' equity of $26M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit: In fiscal 2025 revenue was $12.5M, with a net loss of $5M.
Cash flow: In fiscal 2025 operations used $10.3M of cash.
Latest report: The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on March 30, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR

What Pulsenmore Ltd. does

Pulsenmore Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker PLSM.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	$12.5M	n/a	-$5M	$0.77	-$10.3M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where PLSM ranks in Health care

Revenue$12.5M

#507 of 751 in Health care · Bottom 33%

Net margin-39.6%

#379 of 544 in Health care · Bottom 30%

Free cash flow margin-82.5%

#400 of 490 in Health care · Bottom 18%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Pulsenmore Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

September 17, 2026
Foreign issuer update 6-K
September 8, 2026
Foreign issuer update 6-K
August 31, 2026
Form POS AM filing POS AM
August 31, 2026
Employee stock plan registration S-8
August 31, 2026
Foreign issuer update 6-K
August 19, 2026
Foreign issuer update 6-K
August 17, 2026
Foreign issuer update 6-K
August 6, 2026
Foreign issuer update 6-K
July 13, 2026
Foreign issuer update 6-K
July 2, 2026
IPO registration (foreign issuer) F-1

Recent insider filings (Forms 3, 4 and 144): 10, the latest on March 18, 2026. Insider transactions on SEC

Insider trades

What the people running Pulsenmore Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)

last 90 days

Sold

last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns PLSM

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Holder	Of class	Shares	Filed
Elazar Sonnenschein13G, passive	28.79%	1,872,092	April 28, 2026

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

No insider reported holdings on a Form 4 in the last 12 months.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about PLSM

What does Pulsenmore Ltd. do?

Pulsenmore Ltd. is a company in the Health care sector, listed on NASDAQ as PLSM. Its shares trade on NASDAQ under the ticker PLSM.

What is Pulsenmore Ltd.'s net worth?

Pulsenmore Ltd. has a market value (market cap) of $9.9M at the latest share price, and shareholders' equity of $26M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Pulsenmore Ltd. profitable?

No. In fiscal 2025 it reported a net loss of $5M on revenue of $12.5M.

How much revenue does Pulsenmore Ltd. make?

In fiscal 2025 Pulsenmore Ltd. reported revenue of $12.5M.

When did Pulsenmore Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 30, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 17, 2026.

Similar companies

ICCM

IceCure Medical Ltd.

SINT

Sintx Technologies, Inc.

CODX

Co-Diagnostics, Inc.

INBS

Intelligent Bio Solutions Inc.

Compare PLSM with

Compare PLSM with any company

Follow PLSM

Get an email when Pulsenmore Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Where the numbers come from

Financial figures are the values Pulsenmore Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.